check_circleStudy Completed

Subarachnoid Hemorrhage

Nimodipine in the treatment of traumatic subarachnoid haemorrhage

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

16 - 71 Years
  • -

  • -

Trial summary

Enrollment Goal
592
Trial Dates
July 1997 - March 2000
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Nimotop (Nimodipine, BAYE9736)
Accepts Healthy Volunteer
N/A

Trial design

Efficacy and safety of nimodipine in the treatment of traumatic subarachnoid haemorrhage: a multinational, multicentre, double blind, placebo-controlled study
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A